Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2026-01-24 @ 7:20 AM
Study NCT ID:
NCT05877859
Status:
RECRUITING
Last Update Posted:
2025-05-14
First Post:
2023-05-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
Sponsor:
Organization: